65
Growth Score in past quarter
pts
Heat Score 65 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
844885
StemTech is transforming the ability to produce stem cells for research.
- Zameel Cader: Director & Co-Founder
About the Company
Reprogramming is a difficult, complex process which is expensive to perform and is labour-intensive. StemTech was founded by Oxford University Researchers, who are a world leading research group in stem cell based disease models and drug discovery, to tackle these bottlenecks. StemTech has developed a new method that drastically reduces the cost
and hugely increases the scale of reprogramming. Importantly our method produces the highest quality stem cell lines for research. This means that StemTech can undertake big reprogramming projects for a fraction of the cost and a fraction of time of any of its competitors. This opens new and exciting opportunities for using stem cells in drug discovery.